Showing results (371-380 of 415) with videos related to
Sort By:
Pageof 42
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 11, 2012
[Fibrin glue embolization treating intra-operative type I endoleak of endovascular repair of abdominal aortic aneurysm: long-term result]Jia-Xuan Feng, Qing-sheng Lu, Zai-Ping Jing, et al.Microbial Drug Resistance (Larchmont, N.Y.)|December 31, 2013
Puerarin protects against Staphylococcus aureus-induced injury of human alveolar epithelial A549 cells via downregulating alpha-hemolysin secretionFeng Tang, Wen-Hua Li, Xuan Zhou, et al.Arthritis Care & Research|June 20, 2014
Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritisAlan Kivitz, Ewa Olech, Michael Borofsky, et al.Annals of the Rheumatic Diseases|August 2, 2013
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)Gerd R Burmester, Andrea Rubbert-Roth, Alain Cantagrel, et al.Schizophrenia Bulletin|May 11, 2021
Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to BrainJing Lu, Man-Li Huang, Jin-Hui Li, et al.Iscience|September 4, 2023
Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19Haridha Shivram, Jason A Hackney, Carrie M Rosenberger, et al.Annals of the Rheumatic Diseases|June 10, 2015
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)Gerd R Burmester, Andrea Rubbert-Roth, Alain Cantagrel, et al.Journal of Medicinal Chemistry|July 24, 2024
Discovery of NO Donor-Aurovertin Hybrids as Dual Ferroptosis and Apoptosis Inducers for Treating Triple Negative Breast CancerLie-Feng Ma, Li Li Xu, Ling-Jie Yuan, et al.Molecular & Cellular Proteomics : MCP|January 9, 2019
Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR SignalingQi Zhao, Fang Liu, Yan Cheng, et al.Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|July 17, 2007
[Self-reported prevalence of allergic rhinitis in eleven cities in China]De-Min Han, Luo Zhang, Dan Huang, et al.Pageof 42